Christopher Kenney
Chief Tech/Sci/R&D Officer bij XENON PHARMACEUTICALS INC.
Vermogen: - $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Christopher Kenney
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
| Public Company | Pharmaceuticals: Major | 9 | |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Biotie Therapies, Inc.
1
| Subsidiary | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christopher Kenney via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Sparta Pharmaceuticals, Inc.
 Sparta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Sparta Pharmaceuticals, Inc. acquires the rights to, and develops for commercialization, technologies and drugs for the treatment of diseases. The private company is based in Horsham, PA. Sparta Pharmaceuticals was acquired by SuperGen, Inc. on August 13, 1999 for $12.28 million. The company was founded by Peter N. Christos. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Medical Specialties | Corporate Officer/Principal | |
| DYAX CORP. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Phytera, Inc.
 Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Phytera, Inc. develops plant-based and marine-based pharmaceuticals. The company is headquartered in Shrewsbury, MA. | Miscellaneous Commercial Services | Treasurer | |
| CURIS, INC. | Biotechnology | Corporate Officer/Principal | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Investor Relations Contact | |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Chief Operating Officer | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| Mount Holyoke College | College/University | Undergraduate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Masters Business Admin | |
| University of Cape Town | College/University | Undergraduate Degree Doctorate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member | |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Michael Smith Foundation for Health Research
 Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| COGNITION THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Public Communications Contact Chairman | |
| Universidad del Salvador | College/University | Doctorate Degree | |
| Centre for Molecular Medicine & Therapeutic | Director/Board Member Founder | ||
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Tarix Orphan LLC
 Tarix Orphan LLC Pharmaceuticals: MajorHealth Technology Tarix Orphan LLC is a pharmaceutical company that manufactures pharmaceutical formulation products. The private company is based in Cambridge, MA. The company was founded by Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Pharmaceuticals: Major | President | |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Chairman | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Xenon Pharmaceuticals USA, Inc.
 Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Pharmaceuticals: Major | President Director/Board Member | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer | |
| PERIMETER MEDICAL IMAGING AI, INC. | Medical Specialties | Director/Board Member Investor Relations Contact | |
| ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Director/Board Member | |
| GARDINER HEALTHCARE ACQUISITIONS CORP. | Financial Conglomerates | Corporate Officer/Principal | |
| Morrison Advisory Consulting | Founder |
Statistieken
Internationaal
| Verenigde Staten | 41 |
| Canada | 6 |
| Verenigd Koninkrijk | 2 |
| Zuid-Afrika | 2 |
| Argentinië | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 5 |
| Miscellaneous | 2 |
Operationeel
| Director/Board Member | 138 |
| Corporate Officer/Principal | 100 |
| Independent Dir/Board Member | 53 |
| Chief Tech/Sci/R&D Officer | 41 |
| Undergraduate Degree | 30 |
Sterkste connecties
| Insiders | |
|---|---|
| Clarence Machado | 29 |
| Michael Hayden | 27 |
| Dave Grayzel | 23 |
| Simon Pimstone | 22 |
| Mohammad Azab | 21 |
| Jodie Morrison | 20 |
| Dawn Svoronos | 19 |
| Gary Patou | 17 |
| John S. McBride | 17 |
| Michael Rogers | 16 |
| Steven Gannon | 14 |
| Benedict Osorio | 12 |
| Gillian Cannon | 11 |
| Elizabeth Garofalo | 11 |
| Anthony Caggiano | 10 |
- Beurs
- Insiders
- Christopher Kenney
- Bedrijfsconnecties
